Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 712 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

CoramRx wins URAC Specialty Pharmacy accreditation

CoramRx, an affiliate of Coram Specialty Infusion Services, provides national distribution and local services through specialty pharmacy facilities including more than 85 infusion pharmacies and 65 ambulatory infusion

Ariad seeks FDA approval for leukemia drug

Ponatinib is indicated for patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL). Ariad chairman and CEO Harvey Berger said

ARIAD commences Phase 3 EPIC trial of ponatinib

Evaluation of Ponatinib versus Imatinib in Chronic Myeloid Leukemia (EPIC) trial of ponatinib will be conducted in newly diagnosed patients with chronic myeloid leukemia (CML). The trial will

Neurotez receives US patent for hormone Leptin

Patent issuance comes as Neurotez completes GMP manufacturing of recombinant Leptin and prepares for IND-enabling studies. Preclinical in vitro data and in vivo and interventional studies, along with